Analysis of Circulating Tumor Markers in Blood
NCT04025541
Summary
The circulating tumoral biomarkers in the blood are the object of numerous researches for several decades. The potential clinical interests of these circulating biomarkers are diagnostic, prognostic, predictive of the efficiency of targeted therapies (according to the mutational profile of the cancer), and could allow the study of the mechanisms of resistance under process. In the multiplicity of these blood potential biomarkers joins a permanent evolution of the technological means used to detect them/to quantify, as well as to estimate their clinical utility.
Eligibility
Inclusion Criteria: 1. Patient presenting an invasive tumoral pathology (proved or suspected), whatever is the location or the stage, 2. Man or woman ≥ 18 years, 3. Obtaining of the informed consent signed before any procedure of specific preselection on approval. Exclusion Criteria: 1. Private persons of freedom or under guardianship, 2. Patient whose regular follow-up is impossible for psychological, family, social or geographical reasons, 3. Pregnant woman and/or breast-feeding, 4. Unaffiliated patient to Social Protection System,
Conditions7
Interventions9
Related trials
- B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosidase Enzymes in the Plasma of Patients With a Localized Cancer. — Poitiers University Hospital
- Biobank for Inflammatory Chronic Diseases and Osteoporosis — University Hospital, Toulouse
- Blood Clearance Kinetics of the Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer. — Hospices Civils de Lyon
- Characterisation of Intestinal Microbiota of Patients With Spondyloarthritis or Rheumatoid Arthritis — Assistance Publique - Hôpitaux de Paris
- Characterisation of TLR4+ Blood Cells in Patients With Solid Cancer — Hospices Civils de Lyon
- Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases — University Hospital, Toulouse
- Clinico-biological Collection to Investigate the Physiopathology of Systemic Autoimmune Diseases — University Hospital, Toulouse
- DEPLIPIDO Study: Functional and Lipidomic Analysis of Plasma HDL in Patients With Depression Compared to Controls — Centre Hospitalier Universitaire Dijon
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT04025541